NTEL Healthcare Starts Cervical Cancer Screenings in Vietnam

Why this is here: ServiCare AI technology reportedly achieves 98% sensitivity when detecting high-grade cervical lesions, promising more accurate and faster screenings.

NTEL Healthcare began a cervical cancer screening project for 50,000 female workers in Vietnam with funding from the Vietnamese Ministry of Health. The company is collaborating with the Ho Chi Minh City Labor Federation and local medical institutions to implement the “ServiCare AI” program. This project marks the first time Vietnam’s government has directly funded the integration of innovative digital healthcare technology into its national public screening system.

Since the project launched on May 9th, roughly 12,000 Vietnamese women have completed screenings at hospitals like Hung Vuong. These hospitals are now using ServiCare AI as a primary screening tool, replacing traditional methods. NTEL Healthcare’s “on-device AI” technology delivers results within five seconds, even with limited internet access.

The technology demonstrated 98% sensitivity in detecting high-grade lesions during testing. NTEL Healthcare plans to expand into Southeast Asia, Central Asia, Africa, and Latin America following this initial project. The company anticipates this work will support a planned IPO on the KOSDAQ market in 2027, though broader adoption and long-term efficacy require further study.